Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHR1 | P34998 | 1/20 | 0.33 |
| ▸ | AURKA | O14965 | 1/20 | 0.31 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.31 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.31 |
| ▸ | FFAR2 | O15552 | 2/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19646206 | 0.86 | ACP1 (0.30) | — | |
| SCHEMBL17833609 | 0.84 | — | — | |
| SCHEMBL17833616 | 0.83 | AURKA (0.36) | CRHR1AURKAAURKBPTGER1ALDH1A1 | |
| SCHEMBL17833604 | 0.78 | CRHR1 (0.36) | CRHR1AURKAAURKBALDH1A1KMT2A | |
| SCHEMBL17833630 | 0.74 | CRHR1 (0.35) | CRHR1AURKAAURKBKMT2A | |
| SCHEMBL17833607 | 0.73 | HSP90AA1 (0.36) | CRHR1ALDH1A1KMT2A | |
| SCHEMBL17883779 | 0.72 | CRHR1 (0.41) | CRHR1AURKAAURKBPTGER1KMT2A | |
| SCHEMBL17833617 | 0.71 | CRHR1 (0.34) | CRHR1AURKAAURKBKMT2A | |
| SCHEMBL17833621 | 0.70 | HSP90AA1 (0.35) | CRHR1ALDH1A1LMNAKMT2A | |
| SCHEMBL17833642 | 0.69 | CRHR1 (0.36) | CRHR1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9831445-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-11-28 | — | — | US | disclosed |
| US-9831445-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-11-28 | — | — | US | disclosed |
| US-20160172594-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-06-16 | — | — | US | disclosed |
| US-20160172594-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160172594-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNE2 | CRHR1 858/4885AURKA 279/4885AURKB 484/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.